• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

用于改进参数化和动态寿命分析的癌症生存数据表示

Cancer Survival Data Representation for Improved Parametric and Dynamic Lifetime Analysis.

作者信息

Vandamme Lode K J, Wouters Peter A A F, Slooter Gerrit D, de Hingh Ignace H J T

机构信息

Department of Electrical Engineering, Eindhoven University of Technology, 5612AE Eindhoven, The Netherlands.

Department of Surgical Oncology, Máxima Medical Center, 5504DB Veldhoven, The Netherlands.

出版信息

Healthcare (Basel). 2019 Oct 28;7(4):123. doi: 10.3390/healthcare7040123.

DOI:10.3390/healthcare7040123
PMID:31661787
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6955760/
Abstract

Survival functions are often characterized by a median survival time or a 5-year survival. Whether or not such representation is sufficient depends on tumour development. Different tumour stages have different mean survival times after therapy. The validity of an exponential decay and the origins of deviations are substantiated. The paper shows, that representation of survival data as logarithmic functions visualizes differences better, which allows for differentiating short- and long-term dynamic lifetime. It is more instructive to represent the changing lifetime expectancy for an individual who has survived a certain time, which can be significantly different from the initial expectation just after treatment. Survival data from 15 publications on cancer are compared and re-analysed based on the well-established: (i) exponential decay (ii) piecewise constant hazard (iii) Weibull model and our proposed parametric survival models, (iv) the two-τ and (v) the sliding-τ model. The new models describe either accelerated aging or filtering out of defects with numerical parameters with a physical meaning and add information to the usually provided log-rank -value or median survival. The statistical inhomogeneity in a group by mixing up different tumour stages, metastases and treatments is the main origin for deviations from the exponential decay.

摘要

生存函数通常由中位生存时间或5年生存率来表征。这种表征是否足够取决于肿瘤的发展情况。不同的肿瘤阶段在治疗后的平均生存时间不同。指数衰减的有效性以及偏差的来源得到了证实。本文表明,将生存数据表示为对数函数能更好地直观呈现差异,这有助于区分短期和长期的动态生存期。对于在一定时间后存活的个体,呈现其不断变化的预期寿命更具启发性,这可能与治疗刚结束时的初始预期有显著差异。基于以下成熟方法,对来自15篇癌症相关出版物的生存数据进行了比较和重新分析:(i)指数衰减;(ii)分段恒定风险;(iii)威布尔模型以及我们提出的参数化生存模型;(iv)双τ模型;(v)滑动τ模型。新模型通过具有物理意义的数值参数描述加速衰老或缺陷筛选,并为通常提供的对数秩值或中位生存增加了信息。通过混合不同肿瘤阶段、转移情况和治疗方法导致的组内统计不均匀性是偏离指数衰减的主要原因。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/af00/6955760/60003e5c62ad/healthcare-07-00123-g011.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/af00/6955760/cdb971326a35/healthcare-07-00123-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/af00/6955760/feaeb8f24c62/healthcare-07-00123-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/af00/6955760/3e5bbc0e8671/healthcare-07-00123-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/af00/6955760/7f43fbd4fa34/healthcare-07-00123-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/af00/6955760/667282dc1fa9/healthcare-07-00123-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/af00/6955760/e15da953c660/healthcare-07-00123-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/af00/6955760/59fc3f8dd17f/healthcare-07-00123-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/af00/6955760/b90fecf44fbf/healthcare-07-00123-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/af00/6955760/44d486d4bdf4/healthcare-07-00123-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/af00/6955760/b01dc73379f7/healthcare-07-00123-g010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/af00/6955760/60003e5c62ad/healthcare-07-00123-g011.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/af00/6955760/cdb971326a35/healthcare-07-00123-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/af00/6955760/feaeb8f24c62/healthcare-07-00123-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/af00/6955760/3e5bbc0e8671/healthcare-07-00123-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/af00/6955760/7f43fbd4fa34/healthcare-07-00123-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/af00/6955760/667282dc1fa9/healthcare-07-00123-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/af00/6955760/e15da953c660/healthcare-07-00123-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/af00/6955760/59fc3f8dd17f/healthcare-07-00123-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/af00/6955760/b90fecf44fbf/healthcare-07-00123-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/af00/6955760/44d486d4bdf4/healthcare-07-00123-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/af00/6955760/b01dc73379f7/healthcare-07-00123-g010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/af00/6955760/60003e5c62ad/healthcare-07-00123-g011.jpg

相似文献

1
Cancer Survival Data Representation for Improved Parametric and Dynamic Lifetime Analysis.用于改进参数化和动态寿命分析的癌症生存数据表示
Healthcare (Basel). 2019 Oct 28;7(4):123. doi: 10.3390/healthcare7040123.
2
Applying conventional and saturated generalized gamma distributions in parametric survival analysis of breast cancer.将传统和饱和广义伽马分布应用于乳腺癌的参数生存分析。
Asian Pac J Cancer Prev. 2012;13(5):1829-31. doi: 10.7314/apjcp.2012.13.5.1829.
3
Bayesian inference in a piecewise Weibull proportional hazards model with unknown change points.具有未知变化点的分段威布尔比例风险模型中的贝叶斯推断。
J Anim Breed Genet. 2007 Aug;124(4):176-84. doi: 10.1111/j.1439-0388.2007.00658.x.
4
[Effort to radically cure stage III and IV esophageal carcinoma with simultaneous radiotherapy and chemotherapy in standard clinical practice].[在标准临床实践中采用同步放疗和化疗根治Ⅲ期和Ⅳ期食管癌的努力]
Radiol Med. 2001 Jul-Aug;102(1-2):72-7.
5
An alternative competing risk model to the Weibull distribution for modelling aging in lifetime data analysis.在寿命数据分析中用于建模老化的一种替代竞争风险模型,以替代威布尔分布。
Lifetime Data Anal. 2006 Dec;12(4):481-504. doi: 10.1007/s10985-006-9019-8. Epub 2006 Oct 5.
6
Exponentiated Weibull regression for time-to-event data.用于事件发生时间数据的指数化威布尔回归。
Lifetime Data Anal. 2018 Apr;24(2):328-354. doi: 10.1007/s10985-017-9394-3. Epub 2017 Mar 27.
7
Comparison of nasal intermittent positive pressure ventilation and nasal continuous positive airway pressure treatments using parametric survival models.使用参数生存模型比较经鼻间歇正压通气和经鼻持续气道正压通气治疗
Iran J Pediatr. 2014 Apr;24(2):207-13.
8
A Comparison of Different Analysis Methods for Reconstructed Survival Data to Inform Cost‑Effectiveness Analysis.不同重建生存数据分析方法在成本效益分析中的比较。
Pharmacoeconomics. 2019 Dec;37(12):1525-1536. doi: 10.1007/s40273-019-00830-4.
9
[The prognostic factors in astrocytic tumors: analysis by the Kaplan-Meier method and the Weibull log-linear model].[星形细胞瘤的预后因素:采用Kaplan-Meier法和威布尔对数线性模型进行分析]
No Shinkei Geka. 1996 Sep;24(9):809-15.
10
Weibull-like Model of Cancer Development in Aging.衰老过程中癌症发展的类威布尔模型。
Cancer Inform. 2010 Aug 24;9:179-88. doi: 10.4137/cin.s5460.

引用本文的文献

1
A Population Survival Kinetics Assessment of Extensive Small Cell Lung Cancer and Rationale for Maintenance Therapy.广泛期小细胞肺癌的群体生存动力学评估及维持治疗的理论依据
Curr Oncol. 2025 Apr 29;32(5):258. doi: 10.3390/curroncol32050258.
2
The need for speed in advanced non-small cell lung cancer: A population kinetics assessment.晚期非小细胞肺癌中对速度的需求:群体动力学评估。
Cancer Med. 2021 Dec;10(24):9040-9046. doi: 10.1002/cam4.4411. Epub 2021 Nov 11.
3
Similarities between pandemics and cancer in growth and risk models.

本文引用的文献

1
Comparison of Diagnosis-Specific Survival Scores for Patients with Small-Cell Lung Cancer Irradiated for Brain Metastases.小细胞肺癌脑转移患者特定诊断生存评分的比较
Cancers (Basel). 2019 Feb 16;11(2):233. doi: 10.3390/cancers11020233.
2
Prognostic Factors for Advanced Pancreatic Cancer Treated with Gemcitabine Plus S-1: Retrospective Analysis and Development of a Prognostic Model.吉西他滨联合S-1治疗晚期胰腺癌的预后因素:回顾性分析及预后模型的建立
Cancers (Basel). 2019 Jan 9;11(1):57. doi: 10.3390/cancers11010057.
3
An overview of 25 years of incidence, treatment and outcome of colorectal cancer patients.
大流行病和癌症在生长和风险模型方面的相似性。
Sci Rep. 2021 Jan 11;11(1):349. doi: 10.1038/s41598-020-79458-w.
结直肠癌患者 25 年发病、治疗和转归概述。
Int J Cancer. 2018 Dec 1;143(11):2758-2766. doi: 10.1002/ijc.31785. Epub 2018 Sep 29.
4
International Multicenter Study on the Impact of Extracapsular Lymph Node Involvement in Primary Surgery Adenocarcinoma of the Esophagus on Overall Survival and Staging Systems.关于食管原发性腺癌手术中包膜外淋巴结受累对总生存期和分期系统影响的国际多中心研究
Ann Surg. 2015 Nov;262(5):809-15; discussion 815-6. doi: 10.1097/SLA.0000000000001463.
5
Comparable survival for young rectal cancer patients, despite unfavourable morphology and more advanced-stage disease.尽管形态学较差且疾病更晚期,但年轻直肠癌患者的生存情况相当。
Eur J Cancer. 2015 Sep;51(13):1675-82. doi: 10.1016/j.ejca.2015.06.005. Epub 2015 Jul 6.
6
Large variation in the utilization of liver resections in stage IV colorectal cancer patients with metastases confined to the liver.肝转移局限于肝脏的IV期结直肠癌患者肝切除术的利用率存在很大差异。
Eur J Surg Oncol. 2015 Sep;41(9):1217-25. doi: 10.1016/j.ejso.2015.05.014. Epub 2015 Jun 9.
7
Trends in cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for the treatment of synchronous peritoneal carcinomatosis of colorectal origin in the Netherlands.荷兰结直肠源性同步腹膜癌转移的细胞减灭术及腹腔内热灌注化疗的治疗趋势
Eur J Surg Oncol. 2015 Apr;41(4):466-71. doi: 10.1016/j.ejso.2015.01.018. Epub 2015 Jan 29.
8
The risk factors of early recurrence after hepatectomy in hepatocellular carcinoma.肝细胞癌肝切除术后早期复发的危险因素
Ann Surg Treat Res. 2014 Jun;86(6):283-8. doi: 10.4174/astr.2014.86.6.283. Epub 2014 May 23.
9
Impact of centralization of pancreatic cancer surgery on resection rates and survival.胰腺癌手术集中化对切除率和生存率的影响。
Br J Surg. 2014 Jul;101(8):1000-5. doi: 10.1002/bjs.9468. Epub 2014 May 20.
10
Cytoreduction and hyperthermic intraperitoneal chemotherapy: a feasible and effective option for colorectal cancer patients after emergency surgery in the presence of peritoneal carcinomatosis.细胞减灭术与腹腔热灌注化疗:存在腹膜转移癌的结直肠癌患者急诊手术后的一种可行且有效的选择。
Ann Surg Oncol. 2014 Aug;21(8):2621-6. doi: 10.1245/s10434-014-3655-0. Epub 2014 Mar 27.